Lamb, David J <br/><br/>
BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  06 2016 
 - 554-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.116.233155  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>B-Lymphocytes--drug effects<br/>Basophils--drug effects<br/>Humans<br/>Male<br/>Mast Cells--drug effects<br/>Naphthyridines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrrolidines--administration & dosage<br/>Pyrrolidinones--administration & dosage<br/>Rats<br/>Syk Kinase--antagonists & inhibitors